Literature Screening

In accordance with current legislation, periodic literature screening must be carried out for every drug produced by pharmaceutical companies


This is in order to identify any cases of adverse effects that may have been reported.

In liaison with the team of pharmacovigilance professionals, literature screening should be carried out as follows:

  • on defined products or drugs
  • in databases of scientific articles, such as Medline or EM Base when requested, Toxline, INIST or ARPI
  • internationally, when dealing with parent companies
  • nationally, when dealing with European countries where the products are commercialised

Documentalists also carry out specific research of bibliographies or medical information linked to the preparation of pharmacovigilance reports or any other report linked to product efficacy. This type of research can also be carried out for other fields of vigilance.